On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

CVS Health (NYSE:CVS) is scheduled to announce Q4 earnings results on Wednesday, February 12th, before market open. Analysts expect a profit of $0.92 (-56.6% Y/Y) on revenue of $96.88B (+3.3% Y/Y).